Phosphodiesterase type 5 inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Phosphodiesterase type 5 inhibitors, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension [NA]